- Home
- MBLY vs NBIX Comparison
MBLY vs NBIX Comparison
Compare MBLY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBLY
- NBIX
- Stock Information
- Founded
- MBLY 1999
- NBIX 1992
- Country
- MBLY Israel
- NBIX United States
- Employees
- MBLY N/A
- NBIX N/A
- Industry
- MBLY Computer Software: Prepackaged Software
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MBLY Technology
- NBIX Health Care
- Exchange
- MBLY Nasdaq
- NBIX Nasdaq
- Market Cap
- MBLY 10.5B
- NBIX 11.0B
- IPO Year
- MBLY 2022
- NBIX 1996
- Fundamental
- Price
- MBLY $15.14
- NBIX $106.73
- Analyst Decision
- MBLY Buy
- NBIX Strong Buy
- Analyst Count
- MBLY 21
- NBIX 20
- Target Price
- MBLY $21.11
- NBIX $162.30
- AVG Volume (30 Days)
- MBLY 4.6M
- NBIX 1.8M
- Earning Date
- MBLY 04-24-2025
- NBIX 05-05-2025
- Dividend Yield
- MBLY N/A
- NBIX N/A
- EPS Growth
- MBLY N/A
- NBIX 33.20
- EPS
- MBLY N/A
- NBIX 3.29
- Revenue
- MBLY $1,853,000,000.00
- NBIX $2,355,300,000.00
- Revenue This Year
- MBLY $8.65
- NBIX $15.36
- Revenue Next Year
- MBLY $19.42
- NBIX $16.34
- P/E Ratio
- MBLY N/A
- NBIX $32.44
- Revenue Growth
- MBLY N/A
- NBIX 24.81
- 52 Week Low
- MBLY $10.48
- NBIX $84.23
- 52 Week High
- MBLY $33.26
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- MBLY 57.57
- NBIX 54.68
- Support Level
- MBLY $11.58
- NBIX $101.15
- Resistance Level
- MBLY $13.37
- NBIX $106.20
- Average True Range (ATR)
- MBLY 1.07
- NBIX 4.74
- MACD
- MBLY 0.25
- NBIX 1.87
- Stochastic Oscillator
- MBLY 94.93
- NBIX 96.77
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Others. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.